PHARMASGP HOLDING SE |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22.2 EUR | 0.00% |
|
-0.89% | -1.33% |
| 04-18 | PharmaSGP Holding SE Proposes Dividend for the Financial Year 2023 | CI |
| 04-18 | PharmaSGP Holding SE Announces Changes to Dividend Policy | CI |
| Sales 2023 * | 98.7M 106M 8.45B | Sales 2024 * | 106M 113M 9.08B | Capitalization | 266M 285M 22.81B |
|---|---|---|---|---|---|
| Net income 2023 * | 14M 14.97M 1.2B | Net income 2024 * | 16M 17.11M 1.37B | EV / Sales 2023 * | 2.71 x |
| Net Debt 2023 * | 1.05M 1.12M 89.9M | Net cash position 2024 * | 12.85M 13.74M 1.1B | EV / Sales 2024 * | 2.39 x |
| P/E ratio 2023 * |
18
x | P/E ratio 2024 * |
16
x | Employees | 79 |
| Yield 2023 * |
2.5% | Yield 2024 * |
2.79% | Free-Float | 18.52% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
More news
| 1 week | -0.89% | ||
| Current month | +1.37% | ||
| 1 month | +1.37% | ||
| 3 months | -0.45% | ||
| 6 months | +7.25% | ||
| Current year | -1.33% |
1 week
21.60
22.60
1 month
20.4023.00
Current year
19.8524.50
1 year
17.7029.50
3 years
14.4029.60
5 years
14.4036.00
10 years
14.4036.00
| Managers | Title | Age | Since |
|---|---|---|---|
Natalie Weigand
CEO | Chief Executive Officer | 43 | 31/12/16 |
Michael Rudolf
DFI | Director of Finance/CFO | 50 | 31/12/16 |
Lara Mögenburg
HRO | Human Resources Officer | - | 29/02/20 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Axel Rebien
BRD | Director/Board Member | 52 | 31/05/20 |
Clemens Fischer
CHM | Chairman | 49 | 03/03/20 |
| Director/Board Member | 43 | 03/03/20 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 22.2 | 0.00% | 179 |
| 25/04/24 | 22.2 | 0.00% | 314 |
| 24/04/24 | 22.2 | +1.83% | 1,345 |
| 23/04/24 | 21.8 | +0.93% | 142 |
| 22/04/24 | 21.6 | -3.57% | 748 |
Delayed Quote Xetra, April 26, 2024 at 04:36 pm
More quotes
PharmaSGP Holding SE is a Germany based company, which operates as a pharmaceutical company. The Company produces and develops non-chemical and over-the-counter drugs and other healthcare products.
Sector
Pharmaceuticals
Calendar
28/04/2024
- Q4 2023 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
22.2
EUR
Average target price
37
EUR
Spread / Average Target
+66.67%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -1.33% | 284M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- PSG Stock
